Kala Bio, Inc. (KALA)
0.1901
0.00 (0.00%)
USD |
NASDAQ |
Oct 23, 16:00
0.192
0.00 (0.00%)
After-Hours: 20:00
Kala Bio Market Cap : 3.676M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 3.676M |
| October 22, 2026 | 3.588M |
| October 21, 2026 | 3.69M |
| October 20, 2026 | 3.669M |
| October 19, 2026 | 3.725M |
| October 16, 2026 | 3.673M |
| October 15, 2026 | 3.717M |
| October 14, 2026 | 3.636M |
| October 13, 2026 | 5.028M |
| October 12, 2026 | 5.415M |
| October 09, 2026 | 5.685M |
| October 08, 2026 | 5.736M |
| October 07, 2026 | 6.962M |
| October 06, 2026 | 7.040M |
| October 05, 2026 | 7.011M |
| October 02, 2026 | 7.446M |
| October 01, 2026 | 8.111M |
| September 30, 2026 | 8.303M |
| September 29, 2026 | 9.734M |
| September 28, 2026 | 8.707M |
| September 25, 2026 | 9.198M |
| September 24, 2026 | 10.83M |
| September 23, 2026 | 10.83M |
| September 22, 2026 | 11.58M |
| September 21, 2026 | 10.83M |
| Date | Value |
|---|---|
| September 18, 2026 | 10.42M |
| September 17, 2026 | 10.92M |
| September 16, 2026 | 10.09M |
| September 15, 2026 | 9.819M |
| September 14, 2026 | 10.46M |
| September 11, 2026 | 11.07M |
| September 10, 2026 | 10.89M |
| September 09, 2026 | 10.77M |
| September 08, 2026 | 10.40M |
| September 04, 2026 | 9.811M |
| September 03, 2026 | 10.85M |
| September 02, 2026 | 10.10M |
| September 01, 2026 | 10.29M |
| August 31, 2026 | 13.01M |
| August 28, 2026 | 13.35M |
| August 27, 2026 | 15.71M |
| August 26, 2026 | 15.78M |
| August 25, 2026 | 15.88M |
| August 24, 2026 | 15.38M |
| August 21, 2026 | 15.86M |
| August 20, 2026 | 16.25M |
| August 19, 2026 | 17.41M |
| August 18, 2026 | 17.38M |
| August 17, 2026 | 17.60M |
| August 14, 2026 | 17.58M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.396B |
| Alnylam Pharmaceuticals, Inc. | 29.96B |
| Anika Therapeutics, Inc. | 286.66M |
| Savara, Inc. | 866.79M |
| Vericel Corp. | 2.176B |
Market Cap Related Metrics
| Price to Book Value | 0.4065 |
| Price | 0.1901 |
| Earnings Yield | -38.89K% |